KYMR EBITDA Growth
Kymera Therapeutics Inc · EBITDA Growth
KYMR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-9.14%period ending
KYMR TTM EBITDA YoY % (-21.11% → -9.14%)
Year-over-year change
High-resolution chart · PNG
KYMR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -9.1376% | |
| -31.8395% | |
| -40.1529% | |
| -78.0715% | |
| -75.163% | |
| -54.8717% | |
| -51.0017% | |
| 1.7159% | |
| 1.0303% | |
| 3.5063% | |
| 5.5745% | |
| -8.5773% | |
| -12.8695% | |
| -28.6304% | |
| -55.3062% | |
| -96.7801% | |
| -142.5056% | |
| -164.4505% | |
| -123.3764% | |
| -79.6045% | |
| -21.1101% |